SanBio Company Limited
SNBIF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -5.09 | 0.25 | -1.19 | -0.31 |
| FCF Yield | -7.26% | -12.56% | -17.96% | -11.78% |
| EV / EBITDA | -13.45 | -7.64 | -7.66 | -12.32 |
| Quality | ||||
| ROIC | -117.86% | -102.95% | -126.94% | -145.19% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.20 | 1.87 | 1.58 | 1.44 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | 25.15% | 35.23% | -12.71% | -23.31% |
| Safety | ||||
| Net Debt / EBITDA | 0.72 | 0.84 | 1.25 | 0.46 |
| Interest Coverage | -586.00 | -175.87 | -312.60 | -148.43 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.28 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 1,289.10 |